Metformin Dose for PCOS: 500mg, 1000mg, 1500mg Explained

You are on 500mg and wondering if that is really enough. Or your clinic has told you the plan is to climb to 1500mg over six weeks and you cannot quite tell if that sounds aggressive or routine. The short answer is that the working dose for PCOS fertility is usually 1500 to 2000 mg per day, but how you get there matters more than the number itself.

I want to flag the search-engine framing of this question up front. A lot of people land here typing metformin 500 mg for pcos weight loss or metformin to lose weight pcos, and the expectation is that a particular dose unlocks a particular pound count. That is not how metformin works. The drug nudges insulin signaling, which over months has a small effect on weight (about 2 to 4 kg on average in PCOS trials) and a larger, more relevant effect on ovulation, cycle regularity, and androgen-driven symptoms.¹, ³ The dose conversation is really about how to give the drug enough room to do that job without losing you to side effects in week one.

The standard titration ladder

There is no single PCOS metformin protocol that every clinic follows, but most look something like this. Your prescriber may compress or extend it depending on how you are tolerating each step.

1. Week 1 to 2: 500mg once daily, taken with dinner.
2. Week 3 to 4: 500mg twice daily, with breakfast and dinner.
3. Week 5 to 6: 500mg in the morning, 1000mg with dinner. Total 1500mg.
4. Week 7 onwards: 1000mg twice daily, with food. Total 2000mg. This is the target for most PCOS fertility protocols.

For some people, 1500mg is the working dose and there is no need to climb higher. Others tolerate 2000mg easily and stay there for the duration of treatment. A small number of patients are pushed to 2500mg, but the trial data do not show meaningful additional benefit above 2000mg in PCOS, and GI side effects scale steeply past that point.², ⁴

If you are on extended-release (ER) metformin, the titration is often faster and the dosing is once daily with dinner, because the formulation smooths out the peak that drives most of the GI effects.

What each dose actually accomplishes

This is the part I think about most when I am writing a prescription, because dose is not just a number. Each level on the ladder is doing something different.

500mg per day: this is mostly a tolerance trial. The metabolic effect at this dose is small, and the ovarian effect is barely detectable. The point of week one and two is not to treat PCOS yet, it is to find out whether your gut can handle the drug at all. Some people search metformin 500 mg for pcos weight loss hoping this is the maintenance dose; it almost never is for fertility purposes.

1000mg per day: the first dose at which we see consistent improvement in fasting insulin and modest cycle changes in trials.⁴ For lean PCOS without significant insulin resistance, this is occasionally the working dose. For most other people, 1000mg is a stop on the way to 1500 or 2000mg, not the destination.

1500mg per day: this is where most people with PCOS see real clinical change. Cycles become more regular. Ovulation rate improves. Acne and hirsutism start to soften over months. If you read metformin 1000 mg weight loss pcos content or pcos and metformin dosage threads online and notice that 1500mg keeps showing up as a sweet spot, this is why. It is the lowest dose that delivers most of what metformin is going to deliver.

2000mg per day: the target dose in most PCOS fertility protocols, and the dose used in the largest trials including PPCOS-II / Legro 2007.² The marginal benefit between 1500 and 2000mg is real but smaller than the jump from 1000 to 1500. If you tolerate it, 2000mg is the standard. If you do not, 1500mg is a respectable working dose.

Above 2000mg: diminishing returns and rising side effects. Occasionally used in patients with type 2 diabetes who need additional glycemic control, but for PCOS fertility the cost-benefit is usually unfavorable. The U.S. FDA-approved maximum is 2550mg per day for the immediate-release form and 2000mg per day for many extended-release formulations.⁶

Why slow titration matters

I want to be specific about why we titrate, because this is the single most common reason people abandon metformin before it has a chance to work.

The gastrointestinal side effects of metformin (diarrhea, nausea, bloating, cramping) scale with how much drug is hitting the intestinal lining at once.⁵ When you jump to 1500mg in week one, you produce a peak concentration the gut has not adapted to. Diarrhea follows. Nausea follows. You quit. The patient who slow-walked up from 500 to 1500 over six weeks, taking each dose with food, almost always lands in a different place. By the time they reach the working dose, the gut has adapted, the diarrhea is mild, and the regimen is sustainable.

I have seen this pattern enough times that I will say it directly: the patient who tries to optimize the schedule by climbing fast is the patient who quits in week two. The patient who treats the titration ladder as a slow stairwell, not an obstacle, is the one still on metformin six months later getting the benefit.

If extended-release metformin is available to you, it compresses the titration meaningfully. Many clinics use a 500mg ER once daily for a week, then 1000mg ER, then 1500 to 2000mg ER as a single evening dose. Same destination, fewer stops along the way.

Immediate-release versus extended-release

A practical distinction worth understanding before your next pharmacy pickup.

Immediate-release (IR) metformin: the standard generic. It is cheap, widely stocked, and taken two to three times daily with food. The peak concentration after each dose is higher and shorter, which is what drives GI symptoms in the first few weeks.

Extended-release (ER) metformin: releases over 8 to 12 hours, producing a lower peak and a smoother concentration curve. It is taken once daily with dinner. GI tolerability is meaningfully better in head-to-head studies; one retrospective cohort showed roughly half the rate of GI adverse events on ER compared with IR.⁵

The practical differences:

• ER tablets are larger and cannot be split. The release matrix depends on the intact tablet.
• The shell of the ER tablet sometimes appears in stool. This is the empty matrix, not unabsorbed drug, and is expected.
• ER may cost slightly more, but most insurance plans cover it, and the difference is usually small.
• For patients about to quit IR over GI symptoms, switching to ER is the single most effective rescue.

If your clinic prescribed IR and you are struggling, ask whether the prescription can be changed to ER. Many clinicians default to IR out of habit, not because it is better.

Dose considerations by clinical situation

There is no single right dose for PCOS, and several patient-specific factors influence the target.

Lean PCOS with normal fasting insulin: many of these patients do well at 1000mg total daily, and pushing to 2000mg adds side effects without obvious benefit. The discussion to have with your prescriber is whether the metabolic case for metformin is strong enough at all.

Overweight or obese PCOS with documented insulin resistance: full target dose, 1500 to 2000mg daily, is standard. This is the population in which the Legro 2007 PPCOS-II trial saw the strongest signal from combination therapy.²

Prediabetes or impaired glucose tolerance: target dose plus a plan for ongoing metabolic management, not just fertility-focused dosing. Often continued long after pregnancy.

Type 2 diabetes diagnosed before pregnancy: metformin is part of a broader diabetes plan. Doses up to 2000 or 2500mg daily are common, and continuation through pregnancy is more likely.

Pregnancy continuation: most patients either stop metformin at the positive test or continue at the same dose into the first trimester, depending on indication. I cover that decision in detail in a separate post.

When to adjust the dose

A few common scenarios that come up in clinic.

No ovulation after 12 weeks at target dose: if you have been at 1500 to 2000mg for three months and are still not ovulating reliably on letrozole or clomiphene, dose escalation is unlikely to be the answer. The conversation usually shifts to adding or changing the ovulation-induction drug, not pushing the metformin higher.

GI side effects still unresolved at four weeks at a stable dose: time to consider switching IR to ER, dropping back to the previous step, or, occasionally, accepting a lower working dose.

Positive pregnancy test: talk to your RE and OB within a week. The decision to stop, taper, or continue is individualized, and I cover it in the stopping-at-positive-test post.

Upcoming surgery, IV contrast scan, or severe vomiting illness: most clinicians ask patients to hold metformin temporarily because of a small lactic acidosis risk under those conditions. The drug is resumed once the situation resolves.

Practical things that help at any dose

These small habits do more for tolerability than people expect.

• Always with food: every dose. The single most predictive variable for whether someone stays on metformin.
• Take the larger dose with the larger meal: a 500mg morning and 1000mg dinner split usually beats 750mg twice daily.
• Hydrate: diarrhea on metformin is fluid-loss diarrhea, and the gap between tolerable and miserable is often a glass of water.
• Probiotics: limited but suggestive evidence that they ease GI tolerability in the first weeks. Low risk to try.
• Annual B12 check: long-term metformin use is associated with a small but real risk of B12 deficiency, particularly in people who have been on it for years.⁵ An annual serum B12 is standard.
• Hold for IV contrast scans: your radiology team will tell you, but standard practice is to pause metformin around iodinated contrast.

When dose changes do not help

Sometimes the honest answer is that more metformin is not what you need.

If you have reached 2000mg per day, given it 8 to 12 weeks at that dose, and you are still not ovulating, more metformin is unlikely to change that. The next conversations are about layering letrozole on top, switching the ovulation-induction drug, or stepping up to a different intervention entirely. The point of metformin was always to support the rest of the regimen, not to be the regimen.

A search for losing weight with pcos and metformin that returns dose-escalation advice misses the same point. Above the working dose, the curve flattens. The lever that moves further is rarely the milligrams.

What this means for you

A note for anyone who landed here searching metformin 500 mg for pcos weight loss: dose is one variable, food, formulation, and patience are the others. Bring these questions to your next appointment.

• What is the target dose you have in mind for me, and over how many weeks.
• Was insulin resistance documented in my labs, and what number did we use.
• Will we start with immediate-release or extended-release, and why.
• If GI side effects are rough at the next step, what is the plan.
• How long do you want me at target dose before the next ovulation-induction cycle.
• At a positive pregnancy test, will we stop, taper, or continue.

The number on the bottle matters less than the conversation around it. The right dose is the highest one you can take consistently with food, for long enough to do its job.

What's next

• If you are early in titration and the GI symptoms are taking over: Metformin GI Side Effects: Surviving the First Weeks
• If your RE has added letrozole to the regimen: Metformin and Letrozole: The PCOS Combination Protocol
• If a positive pregnancy test is on the table and you need to know what to do: Stopping Metformin When You Get Pregnant
• For the full pillar on metformin and PCOS fertility: Metformin for PCOS Fertility: How It Helps and When to Start

Sources

1. Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews 2017;(11):CD003053. https://doi.org/10.1002/14651858.CD003053.pub6
2. Lord JM, Flight IHK, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003;327(7421):951-953. https://doi.org/10.1136/bmj.327.7421.951
3. Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Metformin: an old medication of new fashion. European Journal of Endocrinology 2010;162(2):193-212. https://doi.org/10.1530/EJE-09-0733
4. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
5. Sahin Y, Yirmibesh M, Kelestimur F, Aygen E. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 2004;113(2):214-220. https://doi.org/10.1016/j.ejogrb.2003.09.036
6. U.S. Food and Drug Administration. Glucophage (metformin hydrochloride) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf